Islet cell antibodies (ICA) in the sera of nondiabetic relatives of patients with insulindependent diabetes (IDD) are predictive of the disease, a finding that permits the design of intervention strategies to prevent it. However, 85% or more of patients with new onset IDD have no affected relative. We therefore screened 9,696 schoolchildren between the ages of 5 and 18 yr (mean age 10.7 yr) in Pasco County, Florida for ICA in three surveys during 1984/5, 1987/8, and 1990/1 and have followed them prospectively. Approximately 4,000 of these children have been followed for nearly 8 yr. ICA titers > or = 10 Juvenile Diabetes Foundation units on replicate tests were detected in 57 of the children (0.59%). 10 children have developed diabetes so far, and all had ICA detected beforehand. The likelihood of developing IDD among the ICA-positive children was compared with 2,959 age-matched nondiabetic first degree relatives of IDD probands who were screened for ICA by our laboratory during the same time period and also followed prospectively. Of 103 (3.5%) ICApositive relatives, 31 have developed IDD. Life table analysis reveals no statistically significant differences in the probability of developing IDD between the ICA-positive schoolchildren and ICA-positive first degree relatives (P = 0.3). The estimated risk of developing IDD by 7 yr in the ICA-positive schoolchildren was 45% (95% confidence interval […] 
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Insulin-dependent diabetes (IDD)' is a chronic autoimmune disease resulting from immunologically mediated destruction of the insulin-producing pancreatic beta cells, beginning often years before its clinical onset ( 1, 2). The detection of islet cell cytoplasmic autoantibodies (ICA) in the sera of nondiabetic relatives of patients with IDD identifies those most at risk for the disease (3, 4) . High titered ICA, their presence in children rather than in adults, and the additional presence of insulin autoantibodies (IAA) in the sera of such patients all increase the risk of IDD associated with ICA (4) (5) (6) (7) (8) (9) . Autoantibodies to the 64,000-M, islet cell protein (recently identified to be the lower molecular weight isoform ofglutamic acid decarboxylase [GAD65] ) are the most often detectable autoantibodies before diagnosis( IO, 11) .
Whereas these reported studies have been performed in high risk relatives, IDD occurs sporadically in > 85% of patients who have no affected family member (12) . Since the ability to identify impending IDD is an obvious and necessary prerequisite to the design of intervention trials to prevent or delay the onset of clinical disease, we tested the feasibility of using the IDD-associated autoantibodies to screen a general school age population to determine their risk of developing IDD (13) . Younger school aged children were targeted for these studies because of the well known pubertal peak incidence of IDD.
Methods
Patients School population. Children were recruited from schools in the mixed rural-urban Pasco County, in midwest Florida (Table I ). In 1984, the county had 19,297 children enrolled in elementary or middle schools. We requested the participation of 8,691 school children between the ages of 5 and 17 yr through questionnaires and informed consent forms taken home by the children to their parents. Blood samples (5-7 ml) were obtained from 4,873 (56.1%) of these children. Another 10 (0.1 1%) had documented IDD already and were not studied. In 1987, 3 yr after the initial survey, 2,052 (42.0%) of the original ICA-negative children were retested together with a further 1,594 who had not been tested previously. During 1990/ 1, 1,1 11 of the children who had been tested at least once before for ICA and found to be negative were retested, while an additional 3,231 who had not been studied before had ICA determined for the first time. Children in whom ICA were detected were asked to have a second blood test for confirmation. Once the ICA were confirmed, arrangements were then made for serial intra- venous glucose tolerance testing, further autoantibody studies, and HLA-DR serological typing. According to the protocol, children who had a negative ICA result, were either contacted by mail or attempts were made to reach them or their families by telephone biannually to ascertain whether IDD had developed or not. Area pediatricians and regional hospitals were also contacted to request information on any child in our study who might have developed IDD during the observation period, thereby minimizing the chances that any ofthe study subjects could have developed diabetes without our knowledge. Altogether 9,696 individual schoolchildren were screened for ICA in the three surveys with follow-up data (a second blood test for ICA or a telephone follow-up to exclude the presence ofdiabetes) available on 3,854 (40%) who were followed between 2 and 8 yr afterwards.
First degree relatives. In our natural history cohort study, 2,959 age-matched first degree relatives between 5 and 17 yr ofage (mean age 11.1 yr) were tested serially for ICA (14) . Of these, 1,394 have been followed for up to 13 yr.
All studies were approved by the Institutional Review Board at the University of Florida.
Laboratory evaluation
ICA. ICA were determined by indirect immunofluorescence as described previously (6) . All sera testing positive for ICA were titered to an end point dilution, and the results were expressed in Juvenile Diabetes Foundation (JDF) units by comparison with a standard reference serum from the Immunology of Diabetes Workshops (14, 15) . The endpoint titer of the JDF standard was defined at the initial workshop as 80 JDF units. The coefficients of variability between assays for control sera with 20, 40, 80, 160, and 320 JDF units tested in 10 consecutive assays were 7,9,4,5, and 6%, respectively, when expressed geometrically (SD log2JDF units/mean log2JDF units). In the 4th International Islet Cell Antibody Workshop, our laboratory was both 100%o sensitive and specific as determined in blinded analyses oftest sera. The threshold of ICA detection in our laboratory was 5 JDF units. Only ICA of 10 or more JDF units were considered positive.
IAA. IAA were determined by radioimmunoassay as described pre- found to be highly specific (93%) and among the most sensitive (100%) of the laboratories submitting results. HLA-DR typing. HLA-DR typing was offered to all children who tested positive for ICA as well as to a comparative group of ICA-negative schoolchildren. This latter group comprised children who were retested for ICA and had been screened as negative initially. A standard double immunofluorescence assay was used (18) . HLA-DR typings were also performed on as many ofthe autoantibody-positive relatives as possible. Antisera used to type for HLA-DR alleles were purchased from One Lambda Laboratories (Los Angeles, CA).
Biostatistical analyses
The prognostic significance of ICA was determined from the time of the blood sampling at which titers 2 10 JDF units were found. IAA positivity was defined at the first occurrence of insulin ligand binding by a serum sample of > 109 nU/ml. Similarly, the length of follow-up and the duration of ICA and/or IAA positivity were calculated from the time ofthe first positive test. The method ofKaplan and Meier ( 19) was used to construct life tables of the likelihood of developing IDD, and the log rank test was used to compare them (20) . When frequencies were sufficiently large, the Chi-square statistic was used to compare proportions. Otherwise, an exact test of proportions was used (21) . A two-tail P value of 0.05 was established for statistical significance.
Results
Of the 9,696 schoolchildren screened for ICA since 1984, ICA were present in the sera of 57 (0.59%) (Table II) . 10 children (0.1%) have developed IDD by the time of writing and all of them were ICA positive at screening (Tables III and IV) .
Of the 2,959 nondiabetic first degree relatives of IDD subjects tested for ICA during this time period, 1,394 (47%) have been prospectively followed. ICA titers of 10 JDF units or greater were found in 103 (3.5%) of the children. IDD has subsequently developed in 40 (2.7%) ofthe relatives for whom follow-up data was available. (Fig. 1 and Table III) . As we had reported previously for ICA-positive relatives, the additional presence ofIAA in the sera ofICA-positive schoolchildren increased the risk oftheir subsequent development of IDD (P = 0.009). The presence of both ICA and IAA in 11 of the schoolchildren was just as predictive of their subsequent development of IDD (43%) at 5 yr as it was in 43 first degree relatives (34%; P = 0.4) at 5 yr (Fig. 2 and Fig. 3 and Table IV ). The only ICA-positive subject who developed IDD but lacked DR3 and DR4 alleles had the IDD high-risk DR / 8 phenotype. These data, as expected, are similar to other patients with documented IDD that our laboratory has studied (18) . 19 of the remaining 31 ICA-positive subjects (61%) had either the DR3 and/or DR4 alleles, supporting their greater risk for the subsequent development of disease. As seen in Fig. 3 , the risk of developing diabetes in both ICA-positive schoolchildren and relatives who typed HLA-DR3 and/or -DR4 positive was 50% at 7 yr, while the risk of IDD in subjects who did not have either the DR3 or DR4 allele was comparatively lower.
Discussion
Our prospective study documents that it is not only feasible to predict IDD among a general population ofschoolchildren, but that the rate of progression to IDD in ICA-positive subjects with a titer 2 10 JDF units is similar to that found in first degree relatives of IDD probands. We found ICA titers 2 10 JDF units to be present in 0.59% of schoolchildren, which is a frequency that is about twice the reported prevalence ofIDD in the general population (12) . These ICA frequency data relative to that of IDD are similar to those reported in the general Most other studies have reported frequencies of ICA in the general population that far exceed the prevalence of the disease. These include a recent Swedish study in which the frequency ofICA in control children was 3% (25) , with a diabetic prevalence of 0. 15% (26) . Similar ICA frequencies of 4% were found in a study of 1,218 schoolchildren in Finland (27) , 2.2% in 540 children in the United Kingdom (28), and 1.8% in 8,363 French schoolchildren (29) . Several explanations for ICA frequencies that are higher than those we report here are possible. Unusually high IDD prevalence rates are present in northern European countries, particularly Scandinavia. Further, the limits for detection for ICA in those studies were reported to be as low as 1 JDF unit. Since ICA titers < 10 JDF units in nondiabetic relatives often disappear with time, are not reliably reproducible in replicate assays, and are poorly predictive of subsequent progression to disease, we chose to raise our detection level of ICA accordingly ( 14, 29) . The lower limit of ICA detection was set at 5 JDF units, and only those ICA levels 2 10 JDF units were considered positive. Although ICA standardization should allow for valid comparisons between laboratories who are screening for diabetes, there is still considerable variations in the sensitivity and precision of the ICA assay in most investigators' hands, especially at the lower detection lim- its (30, 31 ) . In addition, population size and duration of follow-up are crucial variables.
The additional presence of IAA in the sera of ICA-positive schoolchildren increased the predictability ofthe disease, as has been reported in ICA-positive first degree relatives ( 14) . The presence of IAA by itself in the sera ofthe schoolchildren, however, did not convey any detectable increased risk for the subsequent development of IDD, which is consistent with the low predictability of IAA alone reported in first degree relatives of IDD subjects ( 14) . Antibodies to the islet cell 64,000-M, protein were present in seven out ofseven ICA-positive schoolchildren so studied who had progressed to diabetes. Since these autoantibodies are highly predictive of the prediabetic state in nonaffected relatives ( 10, 32) , their value as a screening tool is promising, but needs to be proven.
A genetic predisposition should exist in those ICA-positive schoolchildren destined to develop IDD. The frequencies of the HLA-DR3 and/or -DR4 IDD-related phenotypes in the ICA schoolchildren were increased in those ICA-positive subjects who subsequently developed IDD, as has been reported previously for ICA-positive relatives ofpatients with IDD ( 14) .
These data suggest that HLA-DR testing may be helpful in predicting which ICA-positive subjects will subsequently develop disease. Presumably, DQ molecular typing will even further improve this predictive ability. DR In summary, in this prospective study over a period now approaching a decade, we report that ICA titers . 10 JDF units in a general population of United States schoolchildren are predictive of the subsequent development of IDD, in a quantitative manner similar to that found in first degree relatives of IDD subjects. The added presence of IAA and IDD-associated HLA-DR3 and/or -DR4 alleles further increases the predictability of IDD. These data confirm the validity of ICA to predict IDD in a general population as well as in relatives genetically predisposed to the development of IDD. The comparison of the risks of IDD in ICA-positive schoolchildren versus relatives should be interpreted with the caveat that the relatively small numbers in our study provide 80% power to detect a 25% or greater difference in the risk of developing IDD and that smaller differences could have gone undetected. Although the yield of positive ICA tests in population screening relative to unaffected first degree relatives is relatively low, such subjects should be included when planning intervention trials.
